DK3334826T5 - Valmue med højt indhold af thebain og fremgangsmåder til fremstilling heraf - Google Patents

Valmue med højt indhold af thebain og fremgangsmåder til fremstilling heraf Download PDF

Info

Publication number
DK3334826T5
DK3334826T5 DK17838267.7T DK17838267T DK3334826T5 DK 3334826 T5 DK3334826 T5 DK 3334826T5 DK 17838267 T DK17838267 T DK 17838267T DK 3334826 T5 DK3334826 T5 DK 3334826T5
Authority
DK
Denmark
Prior art keywords
poppy
preparation
methods
thebaine content
high thebaine
Prior art date
Application number
DK17838267.7T
Other languages
Danish (da)
English (en)
Other versions
DK3334826T3 (da
Inventor
Igor Kovalchuk
Original Assignee
Api Labs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Api Labs Inc filed Critical Api Labs Inc
Application granted granted Critical
Publication of DK3334826T3 publication Critical patent/DK3334826T3/da
Publication of DK3334826T5 publication Critical patent/DK3334826T5/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/11—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (1.14.11)
    • C12Y114/11031—Thebaine 6-O-demethylase (1.14.11.31)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/11—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (1.14.11)
    • C12Y114/11032—Codeine 3-O-demethylase (1.14.11.32)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK17838267.7T 2016-08-12 2017-08-11 Valmue med højt indhold af thebain og fremgangsmåder til fremstilling heraf DK3334826T5 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662374682P 2016-08-12 2016-08-12
CA2941315A CA2941315C (en) 2016-08-12 2016-09-07 High thebaine poppy and methods of producing the same
PCT/CA2017/050951 WO2018027324A1 (en) 2016-08-12 2017-08-11 High thebaine poppy and methods of producing the same

Publications (2)

Publication Number Publication Date
DK3334826T3 DK3334826T3 (da) 2024-01-15
DK3334826T5 true DK3334826T5 (da) 2024-10-07

Family

ID=57243364

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17838267.7T DK3334826T5 (da) 2016-08-12 2017-08-11 Valmue med højt indhold af thebain og fremgangsmåder til fremstilling heraf

Country Status (11)

Country Link
US (2) US10808258B2 (enExample)
EP (1) EP3334826B1 (enExample)
JP (2) JP6906812B2 (enExample)
CN (1) CN110088284A (enExample)
AU (3) AU2017310339B2 (enExample)
CA (1) CA2941315C (enExample)
DK (1) DK3334826T5 (enExample)
ES (1) ES2970324T3 (enExample)
HU (1) HUE065349T2 (enExample)
PT (1) PT3334826T (enExample)
WO (1) WO2018027324A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3553177T1 (sl) 2013-03-15 2021-03-31 The Board Of Trustees Of The Leland Stanford Junior University Mikrobi, ki proizvajajo benzilizokinolinske alkaloide (BIA), in postopka za pripravo in uporabo le-teh
EP3066207A1 (en) 2013-11-04 2016-09-14 The Board Of Trustees Of The University Of the Leland Stanford Junior University Benzylisoquinoline alkaloid (bia) precursor producing microbes, and methods of making and using the same
WO2016179296A1 (en) 2015-05-04 2016-11-10 The Board Of Trustees Of The Leland Stanford Junior University Benzylisoquinoline alkaloid (bia) precursor producing microbes, and methods of making and using the same
CA2983445A1 (en) 2015-05-08 2016-11-17 The Board Of Trustees Of The Leland Stanford Junior University Methods of producing epimerases and benzylisoquinoline alkaloids
CN110114457A (zh) 2016-10-18 2019-08-09 安思雅公司 产生去甲阿片类和nal-阿片类苄基异喹啉生物碱的方法
ES2996607T3 (en) * 2017-05-02 2025-02-12 Sun Pharmaceutical Industries Australia Pty Ltd Modified poppy plants having elevated levels of thebaine
WO2019028390A1 (en) 2017-08-03 2019-02-07 Antheia, Inc. ALKALOID BENZYLISOQUINOLEIN GENETICALLY MODIFIED EPIMERASES AND METHODS FOR PRODUCING BENZYLISOQUINOLINE ALKALOIDS
WO2019165512A1 (en) * 2018-03-02 2019-09-06 Tasmanian Alkaloids Pty Ltd A plant of papaver somniferum with an altered alkaloid profile
MX2021010797A (es) 2019-03-08 2021-12-10 Univ Leland Stanford Junior Células hospederas no vegetales productoras de alcaloides del tropano (ta), y métodos de preparacion y uso de los mismos.
JP7555091B2 (ja) * 2020-02-29 2024-09-24 国立大学法人千葉大学 代謝物センサ及び酵素活性のスクリーニング方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6067749A (en) * 1996-07-11 2000-05-30 Tasmanian Alkaloids Pty. Ltd. Papaver somniferum strain with high concentration of thebaine and oripavine
GB9710809D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
WO1999034663A1 (en) 1998-01-08 1999-07-15 Johnson & Johnson Research Pty. Limited Methods for plant transformation and regeneration
US6453242B1 (en) 1999-01-12 2002-09-17 Sangamo Biosciences, Inc. Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
US6730838B1 (en) 1999-02-12 2004-05-04 Council Of Scientific And Industrial Research Opiumless and alkaloid-free non-narcotic opium poppy (Papaver somniferum) variety “Sujata”
AUPP946399A0 (en) 1999-03-26 1999-04-22 Johnson & Johnson Research Pty. Limited Codeinone reductase from alkaloid poppy
EP1270727A1 (en) 2001-06-11 2003-01-02 Institut für Pflanzenbiochemie Salutaridinol 7-O-acetyltransferase and derivatives thereof
CH695417A5 (de) * 2001-11-15 2006-05-15 Ddr Wassyl Nowicky Dipl Ing Verfahren zur Umsetzung von Alkaloiden.
US6790959B1 (en) 2003-06-05 2004-09-14 Halsey Drug Company, Inc. Process for manufacturing thebaine
US6864370B1 (en) 2003-06-05 2005-03-08 Zhaiwei Lin Process for manufacturing oxycodone
EP1512748A1 (en) 2003-09-03 2005-03-09 Johnson & Johnson Research Pty Limited O-methyltransferases of tetrahydrobenzylisoquinoline alkaloid biosynthesis in papaver somniferum
EP1632565A1 (en) 2004-08-12 2006-03-08 Johnson & Johnson Research Pty Limited Modulation of alkaloid biosynthesis in plants and plants having altered alkaloid biosynthesis
DE102005005449A1 (de) * 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US7795503B2 (en) 2005-02-22 2010-09-14 Ceres, Inc. Modulating plant alkaloids
US7312376B2 (en) 2005-04-20 2007-12-25 Ceres, Inc. Regulatory regions from Papaveraceae
US9131649B2 (en) 2008-03-07 2015-09-15 Tasmanian Alkaloids Pty. Ltd Papaver somniferum strain with high concentration of thebaine
US8541647B2 (en) 2008-05-29 2013-09-24 Tasmania Alkaloids Pty, Ltd. Papaver somniferum with high concentration of codeine
WO2011058446A2 (en) 2009-11-12 2011-05-19 Uti Limited Partnership Thebaine 6-o-demethylase and codeine o-demethylase from papaver somniferum
AU2011256838B2 (en) 2010-05-17 2014-10-09 Sangamo Therapeutics, Inc. Novel DNA-binding proteins and uses thereof
CA2872079A1 (en) * 2012-04-30 2013-11-07 Tpi Enterprises Ltd Papaver bracteatum with modified alkaloid content

Also Published As

Publication number Publication date
EP3334826B1 (en) 2023-10-11
US10808258B2 (en) 2020-10-20
CA2941315C (en) 2018-03-06
JP2019528084A (ja) 2019-10-10
EP3334826A4 (en) 2018-08-08
HUE065349T2 (hu) 2024-05-28
US20190169625A1 (en) 2019-06-06
CA2941315A1 (en) 2016-11-08
AU2019201771A1 (en) 2019-04-04
US20210246460A1 (en) 2021-08-12
CN110088284A (zh) 2019-08-02
JP2021000097A (ja) 2021-01-07
WO2018027324A1 (en) 2018-02-15
DK3334826T3 (da) 2024-01-15
AU2017310339A1 (en) 2018-04-12
JP6906812B2 (ja) 2021-07-21
AU2021232757A1 (en) 2021-10-21
AU2017310339B2 (en) 2019-01-17
ES2970324T3 (es) 2024-05-28
WO2018027324A9 (en) 2019-07-18
EP3334826A1 (en) 2018-06-20
PT3334826T (pt) 2024-02-07

Similar Documents

Publication Publication Date Title
DK3334826T3 (da) Valmue med højt indhold af thebain og fremgangsmåder til fremstilling heraf
DK3310371T3 (da) Glucagon og GLP-1-Co-agonistforbindelser
DK3245225T3 (da) Sammensætninger og fremgangsmåder til behandling og detektering af cancere
DK3540429T3 (da) Indretning og fremgangsmåder til anvendelse af indretning til detektion af hyperammoniæmi
DK3215147T3 (da) Neurodæmpende norketamin-forbindelser og fremgangsmåder
DK3285544T3 (da) Fremgangsmåde og indretning til behandling af indretning-til-indretning-synkroniseringssekvens
DK3212218T3 (da) GIP-agonistforbindelser og fremgangsmåder
DK3556869T3 (da) Sammensætninger og fremgangsmåder til sekventering af polynukleotider
DK3019200T3 (da) Oligonukleotid-ligand-konjugater og fremgangsmåde til fremstiling deraf
DK3134149T3 (da) Mikrokanyler og fremgangsmåder til fremstilling deraf
DK2970456T3 (da) Fremgangsmåder og sammensætninger til levering af mrna-kodede antistoffer
DK3294865T3 (da) Fremgangsmåder til fremstilling af epimeraser og benzylisoquinolinalkaloider
PL3069836T3 (pl) Urządzenie zakładkowe
DK3027097T3 (da) Drikkevaretilberedningsindretning og fremgangsmåde til tilberedning af en drikkevare
DK2692668T3 (da) Indretning og fremgangsmåde til palletering af laster med flere referencer
DK2979399T3 (da) Fremgangsmåde og anordning til justering af latenstid
DK3441381T3 (da) Fremgangsmåde til fremstilling af methanol og indretning til fremstilling af methanol
DK3010838T4 (da) Kapsel med et kapselelement og fremgangsmåde til fremstilling af dette
IL272924B1 (en) Methods for preparing and using endoxifen
DK3080302T3 (da) Metoder og sonder til identifikation af genalleler
DK3052101T3 (da) Konjugater af sn-38 med langsom frigivelse
DK3132049T3 (da) Enhed og fremgangsmåder til anvendelse af enhed til detektering af aminoacidopatier
IL257973B (en) Method and apparatus for establishing connection
DK3091882T3 (da) Fremgangsmåde og indretning til fremstilling af en drik
DK2796049T3 (da) Emballeringslinje med midler til markering af bløddyr og dertil svarende fremgangsmåde